Financial Metrics Unveiled: Agios Pharmaceuticals Inc (AGIO)’s Key Ratios in the Spotlight

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Agios Pharmaceuticals Inc (NASDAQ: AGIO) closed at $44.43 in the last session, down -2.59% from day before closing price of $45.61. In other words, the price has decreased by -$2.59 from its previous closing price. On the day, 0.82 million shares were traded. AGIO stock price reached its highest trading level at $46.24 during the session, while it also had its lowest trading level at $44.16.

Ratios:

We take a closer look at AGIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.71 and its Current Ratio is at 10.09. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on September 27, 2024, Downgraded its rating to Market Perform and sets its target price to $56 from $60 previously.

On February 03, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $41.Piper Sandler initiated its Overweight rating on February 03, 2023, with a $41 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 26 ’24 when Jones Cecilia sold 2,542 shares for $49.03 per share. The transaction valued at 124,634 led to the insider holds 20,158 shares of the business.

Goff Brian sold 11,091 shares of AGIO for $474,140 on Aug 08 ’24. The Chief Executive Officer now owns 78,792 shares after completing the transaction at $42.75 per share. On Aug 08 ’24, another insider, Goff Brian, who serves as the Officer of the company, bought 11,091 shares for $42.75 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGIO now has a Market Capitalization of 2527760384 and an Enterprise Value of 2022489728. For the stock, the TTM Price-to-Sale (P/S) ratio is 80.73 while its Price-to-Book (P/B) ratio in mrq is 3.83. Its current Enterprise Value per Revenue stands at 64.604 whereas that against EBITDA is -5.068.

Stock Price History:

Over the past 52 weeks, AGIO has reached a high of $53.28, while it has fallen to a 52-week low of $19.80. The 50-Day Moving Average of the stock is -2.76%, while the 200-Day Moving Average is calculated to be 25.71%.

Shares Statistics:

According to the various share statistics, AGIO traded on average about 510.52K shares per day over the past 3-months and 823520 shares per day over the past 10 days. A total of 55.95M shares are outstanding, with a floating share count of 55.16M. Insiders hold about 3.05% of the company’s shares, while institutions hold 101.60% stake in the company. Shares short for AGIO as of 1726185600 were 2976882 with a Short Ratio of 5.83, compared to 1723680000 on 3455457. Therefore, it implies a Short% of Shares Outstanding of 2976882 and a Short% of Float of 5.3100000000000005.

Most Popular